Candesic Revenue and Competitors

London, UK

Location

N/A

Total Funding

Consulting

Industry

Estimated Revenue & Valuation

  • Candesic's estimated annual revenue is currently $13.1M per year.(i)
  • Candesic's estimated revenue per employee is $198,000

Employee Data

  • Candesic has 66 Employees.(i)
  • Candesic grew their employee count by 0% last year.

Candesic's People

NameTitleEmail/Phone
1
Engagement ManagerReveal Email/Phone
2
Senior Office ManagerReveal Email/Phone
3
People ManagerReveal Email/Phone
4
Human Resources ManagerReveal Email/Phone
5
Associate PrincipalReveal Email/Phone
6
Software EngineerReveal Email/Phone
7
PartnerReveal Email/Phone
8
Strategy ConsultantReveal Email/Phone
9
Leader the NorthReveal Email/Phone
10
Administrative AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.1M10%N/AN/A
#2
$57.6M23828%N/AN/A
#3
$334.5M108643%N/AN/A
#4
$259.2M82428%$346MN/A
#5
$13.1M660%N/AN/A
#6
$50.1M20747%N/AN/A
#7
$19.8M907%N/AN/A
#8
$2M15-21%N/AN/A
#9
$57.6M2382%N/AN/A
#10
$7.9M455%N/AN/A
Add Company

What Is Candesic?

Candesic provides management consultancy and commercial due diligence services to corporates, private equity and other financial investors, and public sector organisations like the NHS. Our main practices are healthcare and social care, aerospace, defence & security. Candesic was founded in 2002 by Dr Leonid Shapiro and Marc Kitten. The firm is headquartered in London, United Kingdom with additional offices in France, Spain, Italy and India. Commercial Due Diligence (Recent successful Transactions) Acquisition of SERB Pharmaceuticals, valued at 250m according to Mergermarket, by Charterhouse Minority investment in Lucid Group by LDC Acquisition of Carling Group by LDC-owned Fishawack Acquisition of Envision Pharma by Ardian and GHO Capital Acquisition of Priory and Partnerships in Care by BC Partners £320m Acquisition of Orolia by Eurazeo for 100m (public source) Reverse acquisition of Mediclinic by Al Noor for £7.4bn Investment in CEVA Santé Animale by CHD Investments valuing the company over 1.5bn Acquisition of Medical Imaging Partnership by Apposite Capital Metric Capital: investment in Proton Beam Therapy technology Historical transactions AllianceBoots: completed CDD for largest European LBO to date at £12bn Acquisition of Phadia by Cinven for 1.2bn (later sold to Thermo Fisher Scientific for £2.2bn) VCDD Swanton Care: provider of residential care specialised in learning disabilities and Autism Cambian: leading Mental Health provider for patients with Learning Disabilities and Acquired Brain Injuries Danshell: refinancing Strategy Caring Home Group, HC One, HCP REIT, Monarch Alternative Capital: commercial analysis of care homes site Somed: building a private hospital chain in Morocco Bupa: dental market review and strategic options for growth, led to the creation of a leading chain in the UK Schoen Klinik: spanish hospital market workshop GenesisCare: commercial integration of IMO, a Spanish radiotherapy chain

keywords:N/A

N/A

Total Funding

66

Number of Employees

$13.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Candesic News

2022-04-06 - Boutiques Connell Consulting and Eccleston Associates join forces

“I worked with Gonçalo at Candesic for many years,” Connell said. “After he moved to the UK four years ago, built up his team and managed a...

2019-09-08 - Shortlists revealed for North West Dealmakers Awards 2019

... issue share to Waterland (Shoosmiths, Clearwater International, Addleshaw Goddard, Deloitte, PwC, Candesic, GK Strategy, Baldwins)

2019-09-07 - Candesic, CIL, Deloitte and Knight Frank win HealthInvestor Awards

The winners, who were initially short-listed in February, included Candesic, CIL, Deloitte and Knight Frank, who were recognised by clients in ...

2019-07-01 - How technology is helping the NHS get an upgrade

... all of which have seen their waiting time plummet to an average of four minutes, according to Candesic, an independent consulting firm.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.1M6640%N/A
#2
$13.5M66-3%N/A
#3
$8.6M6629%N/A
#4
$8.6M66-16%N/A
#5
$7.5M66-12%N/A